Reply to ‘Critical appraisal of “Comparison of combined oral contraceptives and dienogest for endometriosis-associated pain”’
letter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This reply critically appraises a previous paper that compared combined oral contraceptives and dienogest for endometriosis-associated pain, offering a rebuttal to its conclusions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- <p>Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain</p> 2019
- Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain 2024
- Critical appraisal of "Comparison of combined oral contraceptives and dienogest for endometriosis-associated pain" 2025
References (4)
- Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain via openalex
- Critical appraisal of "Comparison of combined oral contraceptives and dienogest for endometriosis-associated pain" via openalex
- <p>Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain</p> via openalex
- W4405803011 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-04T00:31:40.118107+00:00
License: CC0
· commercial use OK